MedTrace Logo

Comparison Between Tamsulosin and Tadalafil in Management of Benign Prostatic Hyperplasia Long Term Study

NCT05818670 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2023-04-19

No results posted yet for this study

Summary

Comparison between tamsulosin and Tadalafil in management of benign prostatic hyperplasia A Randomised Trial

Conditions

  • BPH

Interventions

DRUG

Tamsulosin

long term follow up

DRUG

Tadalafil

long term follow up

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • ahmed A elqaffas, master · Mansoura urology and nephrology center (UNC)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-11
Primary Completion
2021-09-22
Completion
2022-09-17

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05818670 on ClinicalTrials.gov